HEADER HYDROLASE 16-JAN-24 8VP4 TITLE CRYSTAL STRUCTURE OF JF1CPCASP2 WITH PEPTIDE INHIBITOR ACVDVAD-CHO COMPND MOL_ID: 1; COMPND 2 MOLECULE: JF1CPCASP2; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.22.55; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ACVDVAD-CHO; COMPND 8 CHAIN: D, C; COMPND 9 SYNONYM: ACVDVAD-CHO; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP2, ICH1, NEDD2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS CASPASE-2, INHIBITOR, ALZHEIMER'S DISEASE, DIMER, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.L.FULLER,K.SHI,M.A.WALTERS,B.C.FINZEL REVDAT 2 30-APR-25 8VP4 1 JRNL REVDAT 1 09-APR-25 8VP4 0 JRNL AUTH J.L.FULLER,K.SHI,S.POCKES,B.C.FINZEL,K.H.ASHE,M.A.WALTERS JRNL TITL REENGINEERING OF CIRCULARLY PERMUTED CASPASE-2 TO ENHANCE JRNL TITL 2 ENZYME STABILITY AND ENABLE CRYSTALLOGRAPHIC STUDIES. JRNL REF ACS CHEM.BIOL. V. 20 845 2025 JRNL REFN ESSN 1554-8937 JRNL PMID 40117490 JRNL DOI 10.1021/ACSCHEMBIO.4C00795 REMARK 2 REMARK 2 RESOLUTION. 1.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.70 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 68.6 REMARK 3 NUMBER OF REFLECTIONS : 69871 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 3463 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.7000 - 4.4000 1.00 4160 213 0.1745 0.1933 REMARK 3 2 4.4000 - 3.4900 1.00 3979 192 0.1550 0.1868 REMARK 3 3 3.4900 - 3.0500 1.00 3953 187 0.1828 0.2209 REMARK 3 4 3.0500 - 2.7700 1.00 3911 225 0.1972 0.2204 REMARK 3 5 2.7700 - 2.5700 1.00 3902 189 0.2006 0.2269 REMARK 3 6 2.5700 - 2.4200 1.00 3859 210 0.1933 0.2269 REMARK 3 7 2.4200 - 2.3000 1.00 3869 201 0.1874 0.1871 REMARK 3 8 2.3000 - 2.2000 0.99 3888 177 0.1849 0.2171 REMARK 3 9 2.2000 - 2.1200 0.99 3860 194 0.1864 0.2252 REMARK 3 10 2.1200 - 2.0400 0.98 3774 205 0.1907 0.2135 REMARK 3 11 2.0400 - 1.9800 0.92 3524 197 0.1897 0.2097 REMARK 3 12 1.9800 - 1.9200 0.86 3305 165 0.2032 0.2381 REMARK 3 13 1.9200 - 1.8700 0.80 3081 140 0.2160 0.2349 REMARK 3 14 1.8700 - 1.8300 0.74 2858 172 0.2224 0.2396 REMARK 3 15 1.8300 - 1.7900 0.69 2631 124 0.2305 0.2388 REMARK 3 16 1.7900 - 1.7500 0.60 2313 128 0.2295 0.2388 REMARK 3 17 1.7500 - 1.7100 0.53 2032 109 0.2287 0.2531 REMARK 3 18 1.7100 - 1.6800 0.48 1820 99 0.2305 0.2674 REMARK 3 19 1.6800 - 1.6500 0.43 1616 105 0.2358 0.2767 REMARK 3 20 1.6500 - 1.6200 0.35 1338 68 0.2329 0.2438 REMARK 3 21 1.6200 - 1.6000 0.26 996 49 0.2332 0.2532 REMARK 3 22 1.6000 - 1.5700 0.19 726 53 0.2417 0.2607 REMARK 3 23 1.5700 - 1.5500 0.16 598 38 0.2785 0.2330 REMARK 3 24 1.5500 - 1.5300 0.09 344 19 0.2854 0.2466 REMARK 3 25 1.5300 - 1.5100 0.02 71 4 0.2747 0.4087 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3847 REMARK 3 ANGLE : 0.921 5208 REMARK 3 CHIRALITY : 0.057 584 REMARK 3 PLANARITY : 0.008 683 REMARK 3 DIHEDRAL : 6.834 541 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8VP4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-24. REMARK 100 THE DEPOSITION ID IS D_1000280422. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X17B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69875 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.510 REMARK 200 RESOLUTION RANGE LOW (A) : 37.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.16600 REMARK 200 R SYM FOR SHELL (I) : 1.16600 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.19.2_4158 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NEEDLES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, PH 8.0, 0.2 M SODIUM REMARK 280 CHLORIDE, 20% W/V PEG 6000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.93350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.27750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.77400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.27750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.93350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.77400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-ACETYL-L-VALYL-L-ALPHA-ASPARTYL-L-VALYL-N-[(2R)-1-CARBOXY-3- REMARK 400 OXOPROPAN-2-YL]-L-ALANINAMIDE IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-VALYL-L-ALPHA-ASPARTYL-L-VALYL-N-[(2R)-1-CARBOXY- REMARK 400 3-OXOPROPAN-2-YL]-L-ALANINAMIDE REMARK 400 CHAIN: D, C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 327 REMARK 465 HIS A 328 REMARK 465 HIS A 329 REMARK 465 HIS A 330 REMARK 465 HIS A 331 REMARK 465 HIS A 332 REMARK 465 HIS A 333 REMARK 465 GLY A 334 REMARK 465 LYS A 335 REMARK 465 ASN A 336 REMARK 465 HIS A 337 REMARK 465 ALA A 338 REMARK 465 GLY A 339 REMARK 465 SER A 340 REMARK 465 PRO A 341 REMARK 465 GLY A 342 REMARK 465 CYS A 343 REMARK 465 GLU A 344 REMARK 465 GLU A 345 REMARK 465 SER A 346 REMARK 465 ALA A 347 REMARK 465 ALA A 348 REMARK 465 GLY A 349 REMARK 465 LYS A 350 REMARK 465 GLU A 351 REMARK 465 LYS A 352 REMARK 465 LEU A 353 REMARK 465 PRO A 354 REMARK 465 LYS A 355 REMARK 465 MET A 356 REMARK 465 GLY A 1173 REMARK 465 GLY A 1174 REMARK 465 GLY A 1175 REMARK 465 VAL A 1176 REMARK 465 LYS A 1177 REMARK 465 PRO A 1178 REMARK 465 CYS A 1179 REMARK 465 THR A 1180 REMARK 465 PRO A 1181 REMARK 465 GLU A 1182 REMARK 465 PHE A 1183 REMARK 465 TYR A 1184 REMARK 465 GLN A 1185 REMARK 465 THR A 1186 REMARK 465 ASP A 1333 REMARK 465 MET B 327 REMARK 465 HIS B 328 REMARK 465 HIS B 329 REMARK 465 HIS B 330 REMARK 465 HIS B 331 REMARK 465 HIS B 332 REMARK 465 HIS B 333 REMARK 465 GLY B 334 REMARK 465 LYS B 335 REMARK 465 ASN B 336 REMARK 465 HIS B 337 REMARK 465 ALA B 338 REMARK 465 GLY B 339 REMARK 465 SER B 340 REMARK 465 PRO B 341 REMARK 465 GLY B 342 REMARK 465 CYS B 343 REMARK 465 GLU B 344 REMARK 465 GLU B 345 REMARK 465 SER B 346 REMARK 465 ALA B 347 REMARK 465 ALA B 348 REMARK 465 GLY B 349 REMARK 465 LYS B 350 REMARK 465 GLU B 351 REMARK 465 LYS B 352 REMARK 465 LEU B 353 REMARK 465 PRO B 354 REMARK 465 LYS B 355 REMARK 465 GLY B 1173 REMARK 465 GLY B 1174 REMARK 465 GLY B 1175 REMARK 465 VAL B 1176 REMARK 465 LYS B 1177 REMARK 465 PRO B 1178 REMARK 465 CYS B 1179 REMARK 465 THR B 1180 REMARK 465 PRO B 1181 REMARK 465 GLU B 1182 REMARK 465 PHE B 1183 REMARK 465 TYR B 1184 REMARK 465 GLN B 1185 REMARK 465 THR B 1186 REMARK 465 HIS B 1187 REMARK 465 ASP B 1333 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A1188 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A1189 CG CD OE1 NE2 REMARK 470 LEU A1190 CG CD1 CD2 REMARK 470 ARG A1197 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1213 CG CD OE1 OE2 REMARK 470 LYS A1214 CG CD CE NZ REMARK 470 GLU A1215 CG CD OE1 OE2 REMARK 470 ASP A1323 CG OD1 OD2 REMARK 470 GLU A1324 CG CD OE1 OE2 REMARK 470 ARG A1327 CG CD NE CZ NH1 NH2 REMARK 470 GLN A1332 CG CD OE1 NE2 REMARK 470 LYS B 372 CG CD CE NZ REMARK 470 PHE B1188 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B1189 CG CD OE1 NE2 REMARK 470 LEU B1190 CG CD1 CD2 REMARK 470 GLN B1195 CG CD OE1 NE2 REMARK 470 GLU B1213 CG CD OE1 OE2 REMARK 470 LYS B1214 CG CD CE NZ REMARK 470 GLU B1215 CG CD OE1 OE2 REMARK 470 ASP B1323 CG OD1 OD2 REMARK 470 GLU B1324 CG CD OE1 OE2 REMARK 470 ARG B1327 CG CD NE CZ NH1 NH2 REMARK 470 GLN B1332 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS B 1320 C ASA D 6 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 421 70.79 -163.27 REMARK 500 GLU A1215 22.76 -75.84 REMARK 500 ALA B 421 70.26 -159.11 REMARK 500 VAL B1208 -30.96 -130.82 REMARK 500 REMARK 500 REMARK: NULL DBREF 8VP4 A 334 1173 UNP P42575 CASP2_HUMAN 334 448 DBREF 8VP4 A 1176 1333 UNP P42575 CASP2_HUMAN 176 333 DBREF 8VP4 B 334 1173 UNP P42575 CASP2_HUMAN 334 448 DBREF 8VP4 B 1176 1333 UNP P42575 CASP2_HUMAN 176 333 DBREF 8VP4 D 1 6 PDB 8VP4 8VP4 1 6 DBREF 8VP4 C 1 6 PDB 8VP4 8VP4 1 6 SEQADV 8VP4 MET A 327 UNP P42575 INITIATING METHIONINE SEQADV 8VP4 HIS A 328 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS A 329 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS A 330 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS A 331 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS A 332 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS A 333 UNP P42575 EXPRESSION TAG SEQADV 8VP4 ALA A 347 UNP P42575 ASP 347 CONFLICT SEQADV 8VP4 GLY A 1174 UNP P42575 LINKER SEQADV 8VP4 GLY A 1175 UNP P42575 LINKER SEQADV 8VP4 MET B 327 UNP P42575 INITIATING METHIONINE SEQADV 8VP4 HIS B 328 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS B 329 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS B 330 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS B 331 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS B 332 UNP P42575 EXPRESSION TAG SEQADV 8VP4 HIS B 333 UNP P42575 EXPRESSION TAG SEQADV 8VP4 ALA B 347 UNP P42575 ASP 347 CONFLICT SEQADV 8VP4 GLY B 1174 UNP P42575 LINKER SEQADV 8VP4 GLY B 1175 UNP P42575 LINKER SEQRES 1 A 282 MET HIS HIS HIS HIS HIS HIS GLY LYS ASN HIS ALA GLY SEQRES 2 A 282 SER PRO GLY CYS GLU GLU SER ALA ALA GLY LYS GLU LYS SEQRES 3 A 282 LEU PRO LYS MET ARG LEU PRO THR ARG SER ASP MET ILE SEQRES 4 A 282 CYS GLY TYR ALA CYS LEU LYS GLY THR ALA ALA MET ARG SEQRES 5 A 282 ASN THR LYS ARG GLY SER TRP TYR ILE GLU ALA LEU ALA SEQRES 6 A 282 GLN VAL PHE SER GLU ARG ALA CYS ASP MET HIS VAL ALA SEQRES 7 A 282 ASP MET LEU VAL LYS VAL ASN ALA LEU ILE LYS ASP ARG SEQRES 8 A 282 GLU GLY TYR ALA PRO GLY THR GLU PHE HIS ARG CYS LYS SEQRES 9 A 282 GLU MET SER GLU TYR CYS SER THR LEU CYS ARG HIS LEU SEQRES 10 A 282 TYR LEU PHE PRO GLY GLY GLY VAL LYS PRO CYS THR PRO SEQRES 11 A 282 GLU PHE TYR GLN THR HIS PHE GLN LEU ALA TYR ARG LEU SEQRES 12 A 282 GLN SER ARG PRO ARG GLY LEU ALA LEU VAL LEU SER ASN SEQRES 13 A 282 VAL HIS PHE THR GLY GLU LYS GLU LEU GLU PHE ARG SER SEQRES 14 A 282 GLY GLY ASP VAL ASP HIS SER THR LEU VAL THR LEU PHE SEQRES 15 A 282 LYS LEU LEU GLY TYR ASP VAL HIS VAL LEU CYS ASP GLN SEQRES 16 A 282 THR ALA GLN GLU MET GLN GLU LYS LEU GLN ASN PHE ALA SEQRES 17 A 282 GLN LEU PRO ALA HIS ARG VAL THR ASP SER CYS ILE VAL SEQRES 18 A 282 ALA LEU LEU SER HIS GLY VAL GLU GLY ALA ILE TYR GLY SEQRES 19 A 282 VAL ASP GLY LYS LEU LEU GLN LEU GLN GLU VAL PHE GLN SEQRES 20 A 282 LEU PHE ASP ASN ALA ASN CYS PRO SER LEU GLN ASN LYS SEQRES 21 A 282 PRO LYS MET PHE PHE ILE GLN ALA CYS ARG GLY ASP GLU SEQRES 22 A 282 THR ASP ARG GLY VAL ASP GLN GLN ASP SEQRES 1 B 282 MET HIS HIS HIS HIS HIS HIS GLY LYS ASN HIS ALA GLY SEQRES 2 B 282 SER PRO GLY CYS GLU GLU SER ALA ALA GLY LYS GLU LYS SEQRES 3 B 282 LEU PRO LYS MET ARG LEU PRO THR ARG SER ASP MET ILE SEQRES 4 B 282 CYS GLY TYR ALA CYS LEU LYS GLY THR ALA ALA MET ARG SEQRES 5 B 282 ASN THR LYS ARG GLY SER TRP TYR ILE GLU ALA LEU ALA SEQRES 6 B 282 GLN VAL PHE SER GLU ARG ALA CYS ASP MET HIS VAL ALA SEQRES 7 B 282 ASP MET LEU VAL LYS VAL ASN ALA LEU ILE LYS ASP ARG SEQRES 8 B 282 GLU GLY TYR ALA PRO GLY THR GLU PHE HIS ARG CYS LYS SEQRES 9 B 282 GLU MET SER GLU TYR CYS SER THR LEU CYS ARG HIS LEU SEQRES 10 B 282 TYR LEU PHE PRO GLY GLY GLY VAL LYS PRO CYS THR PRO SEQRES 11 B 282 GLU PHE TYR GLN THR HIS PHE GLN LEU ALA TYR ARG LEU SEQRES 12 B 282 GLN SER ARG PRO ARG GLY LEU ALA LEU VAL LEU SER ASN SEQRES 13 B 282 VAL HIS PHE THR GLY GLU LYS GLU LEU GLU PHE ARG SER SEQRES 14 B 282 GLY GLY ASP VAL ASP HIS SER THR LEU VAL THR LEU PHE SEQRES 15 B 282 LYS LEU LEU GLY TYR ASP VAL HIS VAL LEU CYS ASP GLN SEQRES 16 B 282 THR ALA GLN GLU MET GLN GLU LYS LEU GLN ASN PHE ALA SEQRES 17 B 282 GLN LEU PRO ALA HIS ARG VAL THR ASP SER CYS ILE VAL SEQRES 18 B 282 ALA LEU LEU SER HIS GLY VAL GLU GLY ALA ILE TYR GLY SEQRES 19 B 282 VAL ASP GLY LYS LEU LEU GLN LEU GLN GLU VAL PHE GLN SEQRES 20 B 282 LEU PHE ASP ASN ALA ASN CYS PRO SER LEU GLN ASN LYS SEQRES 21 B 282 PRO LYS MET PHE PHE ILE GLN ALA CYS ARG GLY ASP GLU SEQRES 22 B 282 THR ASP ARG GLY VAL ASP GLN GLN ASP SEQRES 1 D 6 ACE VAL ASP VAL ALA ASA SEQRES 1 C 6 ACE VAL ASP VAL ALA ASA HET ACE D 1 3 HET ASA D 6 8 HET ACE C 1 3 HET ASA C 6 8 HETNAM ACE ACETYL GROUP HETNAM ASA ASPARTIC ALDEHYDE FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 ASA 2(C4 H7 N O3) FORMUL 5 HOH *285(H2 O) HELIX 1 AA1 TRP A 385 ALA A 398 1 14 HELIX 2 AA2 HIS A 402 ARG A 417 1 16 HELIX 3 AA3 HIS A 1187 ALA A 1191 5 5 HELIX 4 AA4 GLY A 1221 LEU A 1236 1 16 HELIX 5 AA5 THR A 1247 GLN A 1260 1 14 HELIX 6 AA6 LEU A 1261 THR A 1267 5 7 HELIX 7 AA7 LEU A 1293 PHE A 1300 1 8 HELIX 8 AA8 CYS A 1305 GLN A 1309 5 5 HELIX 9 AA9 TRP B 385 ALA B 398 1 14 HELIX 10 AB1 HIS B 402 ARG B 417 1 16 HELIX 11 AB2 GLY B 1221 LEU B 1236 1 16 HELIX 12 AB3 THR B 1247 GLN B 1260 1 14 HELIX 13 AB4 LEU B 1261 VAL B 1266 5 6 HELIX 14 AB5 LEU B 1293 PHE B 1300 1 8 HELIX 15 AB6 CYS B 1305 GLN B 1309 5 5 SHEET 1 AA112 TYR A1238 CYS A1244 0 SHEET 2 AA112 GLY A1200 SER A1206 1 N ALA A1202 O HIS A1241 SHEET 3 AA112 SER A1269 LEU A1275 1 O ALA A1273 N LEU A1203 SHEET 4 AA112 LYS A1313 GLN A1318 1 O GLN A1318 N LEU A1274 SHEET 5 AA112 MET A 364 TYR A 368 1 N GLY A 367 O ILE A1317 SHEET 6 AA112 GLU A 434 SER A 437 -1 O GLU A 434 N TYR A 368 SHEET 7 AA112 GLU B 434 SER B 437 -1 O TYR B 435 N SER A 437 SHEET 8 AA112 MET B 364 TYR B 368 -1 N TYR B 368 O GLU B 434 SHEET 9 AA112 LYS B1313 GLN B1318 1 O PHE B1315 N GLY B 367 SHEET 10 AA112 SER B1269 LEU B1275 1 N CYS B1270 O MET B1314 SHEET 11 AA112 GLY B1200 SER B1206 1 N LEU B1203 O ALA B1273 SHEET 12 AA112 TYR B1238 CYS B1244 1 O HIS B1241 N ALA B1202 SHEET 1 AA2 3 GLY A 383 SER A 384 0 SHEET 2 AA2 3 MET A 377 ASN A 379 -1 N ASN A 379 O GLY A 383 SHEET 3 AA2 3 ASP C 3 ALA C 5 -1 O VAL C 4 N ARG A 378 SHEET 1 AA3 3 GLY A1278 VAL A1279 0 SHEET 2 AA3 3 ALA A1282 TYR A1284 -1 O ALA A1282 N VAL A1279 SHEET 3 AA3 3 LEU A1290 GLN A1292 -1 O LEU A1291 N ILE A1283 SHEET 1 AA4 2 VAL A1329 ASP A1330 0 SHEET 2 AA4 2 ARG B 357 LEU B 358 -1 O LEU B 358 N VAL A1329 SHEET 1 AA5 3 GLY B 383 SER B 384 0 SHEET 2 AA5 3 MET B 377 ASN B 379 -1 N ASN B 379 O GLY B 383 SHEET 3 AA5 3 ASP D 3 ALA D 5 -1 O VAL D 4 N ARG B 378 SHEET 1 AA6 3 GLY B1278 VAL B1279 0 SHEET 2 AA6 3 ALA B1282 TYR B1284 -1 O ALA B1282 N VAL B1279 SHEET 3 AA6 3 LEU B1290 GLN B1292 -1 O LEU B1291 N ILE B1283 SSBOND 1 CYS A 436 CYS B 436 1555 1555 2.09 LINK SG CYS A1320 C ASA C 6 1555 1555 1.96 LINK C ACE D 1 N VAL D 2 1555 1555 1.32 LINK C ALA D 5 N ASA D 6 1555 1555 1.33 LINK C ACE C 1 N VAL C 2 1555 1555 1.33 LINK C ALA C 5 N ASA C 6 1555 1555 1.33 CISPEP 1 ARG A 1197 PRO A 1198 0 -0.76 CISPEP 2 ARG B 1197 PRO B 1198 0 6.45 CRYST1 55.867 101.548 112.555 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017900 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009848 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008885 0.00000 CONECT 642 2494 CONECT 1769 3771 CONECT 2494 642 CONECT 3700 3701 3702 3703 CONECT 3701 3700 CONECT 3702 3700 CONECT 3703 3700 CONECT 3727 3730 CONECT 3730 3727 3731 CONECT 3731 3730 3732 3734 CONECT 3732 3731 3733 CONECT 3733 3732 CONECT 3734 3731 3735 CONECT 3735 3734 3736 3737 CONECT 3736 3735 CONECT 3737 3735 CONECT 3739 3740 3741 3742 CONECT 3740 3739 CONECT 3741 3739 CONECT 3742 3739 CONECT 3766 3769 CONECT 3769 3766 3770 CONECT 3770 3769 3771 3773 CONECT 3771 1769 3770 3772 CONECT 3772 3771 CONECT 3773 3770 3774 CONECT 3774 3773 3775 3776 CONECT 3775 3774 CONECT 3776 3774 MASTER 387 0 4 15 26 0 0 6 4015 4 29 46 END